Viewing Study NCT00003694


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-03-08 @ 11:21 PM
Study NCT ID: NCT00003694
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelogenous Leukemia, BCR-ABL1 Positive View
None Chronic Phase Chronic Myelogenous Leukemia View
Keywords: